The protein PNA5 showed to help with cognitive dysfunction in mice. The researchers hope there is a path to human clinical ...

Beyfortus, a long-acting RSV antibody treatment for infants, will launch in Korea next month, aiming to address rising ...

Researchers have discovered a new connection between Parkinson’s disease development and the immune system. Researchers at ...

A drug trial underway at Macquarie University is taking advantage of an early warning sign of Parkinson's in the hope of ...

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of Alzheimer's disease, ...

The disease is characterized by progressive motor, cognitive, and psychiatric decline. Three treatments are approved to treat ...

DBS is a well-established neurosurgical technique that involves implanting electrodes into specific brain regions to modulate ...

Transaction Creates Opportunity to Share in Potential Upside of Pharma Two B’s Late-Clinical Stage Candidate to Treat Parkinson’s DiseaseHepion’s ...

We think UCB is in good financial health, with solid earnings and cash flow generation. UCB has deleveraged over the years, and it ended 2023 with about EUR 2.2 billion in net debt on its balance ...

The University of Colorado Anschutz Medical Campus will receive up to $46 million from the Advanced Research Projects Agency ...

Each scholarship is worth $166,174. This means a total of nearly $500,000 is being injected into pushing vital research ...

A new systematic review and meta-analysis investigated the link between alcohol consumption and androgenetic alopecia (AGA).